Core Viewpoint - Rosen Law Firm is reminding investors who purchased Zynex, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Zynex securities between March 13, 2023, and March 11, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by May 19, 2025 [2] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3] Group 3: Allegations Against Zynex - The lawsuit alleges that Zynex failed to disclose that it shipped products in excess of need, which inflated its revenue [4] - It is claimed that Zynex's practice of filing false claims attracted scrutiny from insurers, leading to potential adverse consequences, including removal from insurer networks and federal penalties [4] - The lawsuit asserts that the positive statements made by Zynex regarding its business and operations were materially misleading [4]

Core Viewpoint - Zynex, Inc. is facing allegations of issuing materially false and misleading statements regarding its business practices, particularly related to inflated revenue and improper product shipments during the class period from March 13, 2023, to March 11, 2025 [1]. Group 1: Allegations Against Zynex, Inc. - The complaint alleges that Zynex shipped products, including electrodes, in excess of need, leading to inflated revenue [1]. - The company's practice of filing false claims has drawn scrutiny from insurers, including the U.S. military health insurance program, Tricare [1]. - As a result of these practices, Zynex is likely to face adverse consequences, including potential removal from insurer networks and penalties from the federal government [1]. - The positive statements made by the defendants regarding the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]. Group 2: Class Action Details - Shareholders who purchased shares of ZYXI during the specified class period are encouraged to contact the Gross Law Firm for possible lead plaintiff appointment [1][2]. - The deadline for shareholders to register for the class action and seek lead plaintiff status is May 19, 2025 [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive status updates throughout the lifecycle of the case [2].

Core Viewpoint - A class action securities lawsuit has been filed against Zynex, Inc. alleging securities fraud that affected investors between March 13, 2023, and March 11, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Zynex shipped products, including electrodes, in excess of need, leading to inflated revenue [2]. - It is alleged that the company's practice of filing false claims attracted scrutiny from insurers, including the U.S. military health insurance program, Tricare [2]. - The lawsuit suggests that Zynex is likely to face adverse consequences, such as removal from insurer networks and penalties from the federal government [2]. - Defendants' positive statements regarding the company's business, operations, and prospects are claimed to be materially misleading and lacking a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses in Zynex, Inc. during the relevant time frame have until May 19, 2025, to request to be appointed as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and participation does not require serving as a lead plaintiff [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the top securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against Zynex, Inc. alleging securities fraud that affected investors between March 13, 2023, and March 11, 2025 [1][2]. Group 1: Allegations and Impact - The lawsuit claims that Zynex shipped products, including electrodes, in excess of need, leading to inflated revenue [2]. - It is alleged that Zynex's practice of filing false claims attracted scrutiny from insurers, including the U.S. military health insurance program, Tricare [2]. - The lawsuit suggests that Zynex may face adverse consequences such as removal from insurer networks and penalties from the federal government due to these practices [2]. - Defendants' positive statements regarding Zynex's business and operations were claimed to be materially misleading and lacked a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses in Zynex, Inc. during the relevant timeframe have until May 19, 2025, to request to be appointed as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and participation does not require serving as a lead plaintiff [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the top securities litigation firms in the United States [4].

Core Viewpoint - A securities class action lawsuit has been filed against Zynex, Inc. for allegedly misleading investors regarding its revenue practices and product shipments [1][3]. Company Overview - Zynex, Inc. is a medical device company based in Englewood, CO, specializing in electrotherapy devices for pain management and rehabilitation [2]. Lawsuit Details - The lawsuit claims that Zynex shipped products, including electrodes, beyond actual demand, allowing the company to inflate its revenue [3]. - It is alleged that Zynex's practice of filing false claims attracted scrutiny from insurers, including Tricare, which could lead to adverse consequences such as removal from insurer networks and federal penalties [3]. Investor Information - Investors who purchased Zynex securities during the class period (March 13, 2023, to March 11, 2025) have until May 19, 2025, to seek appointment as lead plaintiff [2].

Core Viewpoint - Zynex, Inc. is facing a class action lawsuit due to allegations of issuing misleading statements and inflating revenue through improper business practices during the class period from March 13, 2023, to March 11, 2025 [3]. Summary by Relevant Sections Allegations - The complaint alleges that Zynex shipped products, including electrodes, in excess of need, leading to inflated revenue [3]. - The company's practice of filing false claims has drawn scrutiny from insurers, including the U.S. military health insurance program, Tricare [3]. - As a result of these practices, Zynex is likely to face adverse consequences, including removal from insurer networks and federal penalties [3]. - The positive statements made by the defendants regarding the company's business and prospects were materially misleading and lacked a reasonable basis [3]. Class Action Details - Shareholders who purchased shares of ZYXI during the specified class period are encouraged to register for the class action [4]. - The deadline for shareholders to seek lead plaintiff status is May 19, 2025 [4]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - A class-action lawsuit has been filed against Zynex, Inc. alleging that the company misled investors by inflating revenue through excessive and unnecessary shipments of medical supplies to patients [1][2][3]. Group 1: Lawsuit Details - The lawsuit, Tuncel v. Zynex, Inc., seeks to represent individuals and entities who purchased Zynex securities between March 13, 2023, and March 11, 2025, with a lead plaintiff deadline of May 19, 2025 [2][3]. - The complaint alleges that Zynex engaged in a scheme to inflate reported revenue by sending more products than medically necessary, which drew scrutiny from insurers like Tricare [3][4]. - Following a report in the medical journal STAT detailing Zynex's alleged oversupplying scheme, the company's stock price fell by over 5% [4]. Group 2: Financial Impact - Zynex disclosed a significant revenue shortfall for Q4 2024, attributing it to slower payments from certain payers, including a temporary suspension of payments from Tricare [5]. - The announcement of the revenue shortfall led to a sharp decline in Zynex's share price, which plummeted by more than 51% [5]. - In Q1 2025, Zynex reported net revenue of $26.6 million, down from $46.5 million in the same period of 2024, with a gross profit margin contracting to 69% from 80% [6]. Group 3: Future Outlook - Zynex has issued a muted revenue guidance of $27 million for Q2 2025 and anticipates an earnings per share (EPS) loss of $0.20, withholding full-year financial guidance due to uncertainty with Tricare [8]. - The CEO of Zynex acknowledged the impact of the Tricare payment suspension on revenue and indicated that the company is initiating a restructuring effort [7].

Core Viewpoint - A class action securities lawsuit has been filed against Zynex, Inc. for alleged securities fraud affecting investors between March 13, 2023, and March 11, 2025 [1] Group 1: Allegations - The lawsuit claims that Zynex shipped products, including electrodes, in excess of need, leading to inflated revenue [2] - It is alleged that Zynex's practice of filing false claims attracted scrutiny from insurers, including the U.S. military health insurance program, Tricare [2] - The lawsuit suggests that Zynex may face adverse consequences such as removal from insurer networks and federal penalties due to these practices [2] - Defendants' positive statements regarding Zynex's business and operations were claimed to be materially misleading and lacked a reasonable basis [2] Group 2: Legal Process - Investors who suffered losses in Zynex, Inc. during the specified timeframe have until May 19, 2025, to request to be appointed as lead plaintiff [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

Core Viewpoint - Zynex, Inc. is facing a class action lawsuit due to allegations of issuing misleading statements and inflating revenue through improper business practices during the class period from March 13, 2023, to March 11, 2025 [3]. Summary by Relevant Sections Allegations - The complaint alleges that Zynex shipped products, including electrodes, in excess of need, leading to inflated revenue [3]. - The company's practice of filing false claims has drawn scrutiny from insurers, including the U.S. military health insurance program, Tricare [3]. - As a result of these practices, Zynex is likely to face adverse consequences, including removal from insurer networks and potential penalties from the federal government [3]. - The positive statements made by the defendants regarding the company's business and prospects were materially misleading and lacked a reasonable basis [3]. Class Action Details - The class period for the lawsuit is defined as March 13, 2023, to March 11, 2025 [3]. - Shareholders who purchased shares during this period are encouraged to register for the class action, with a deadline set for May 19, 2025 [4]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Zynex, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements, leading to inflated revenue and potential penalties from insurers and the federal government [1][2]. Group 1: Allegations Against Zynex, Inc. - The complaint alleges that Zynex shipped products, including electrodes, in excess of need, resulting in inflated revenue [1]. - The company's practice of filing false claims has drawn scrutiny from insurers, including the U.S. military health insurance program, Tricare [1]. - It is reasonably likely that Zynex will face adverse consequences, including removal from insurer networks and penalties from the federal government [1]. - The positive statements made by the defendants about the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]. Group 2: Class Action Details - The class period for the lawsuit is from March 13, 2023, to March 11, 2025 [1]. - Shareholders are encouraged to register for the class action by May 19, 2025, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive status updates throughout the case [2]. Group 3: About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and engage in good corporate citizenship [3].